港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥外包概念

2,304.191

+77.4413.48%

漲家數：8

跌家數：- -

平家數：- -

市盈率：- -

高：2,393.469

開：2,227.803

低：2,227.803

收：2,226.750

資料載入中...

藥明生物(02269)出現大手買入19.95萬股，成交價$25.7，涉資512.715萬

阿斯达克财经

聯邦制藥(03933)：UBT37034注射液獲美國FDA新藥臨牀試驗批准

康諾思騰自主創新研發手術機器人於英國啓動首輪臨牀試驗

阿斯达克财经

昭衍新藥盤中異動股價大漲5.14%報20.650港元

泰格醫藥(03347)股價上升5.038%，現價港幣$49.0

阿斯达克财经

無錫藥明康德實施2025年首次A股回購計劃累計回購近300萬股

中访网数据

上證180醫藥衞生指數上漲2.21%，前十大權重包含藥明康德等

【和鉑醫藥-B(02142.HK)：恩凱賽藥已完成A+++輪融資融資近1億元】智通財經APP訊，和鉑醫藥-B(0214

【藥明生物(02269.HK)7月9日耗資約2.98億港元回購1150萬股】智通財經APP訊，藥明生物(02269.HK

復宏漢霖(2696.HK)HLX43獲多國批准開展NSCLC國際多中心II期臨牀

智飛生物：重組帶狀皰疹疫苗獲臨牀試驗批准

【復星醫藥(02196.HK)：復邁寧®用於治療兒童低級別腦膠質瘤於中國境內啓動Ⅲ期臨牀試驗】智通財經APP訊，復星醫藥

【熱門行業】創新藥板塊逆勢上漲政策+出海雙輪驅動價值重估

尾盤A股突變！銀行板塊再度走強創新藥概念盤中走勢活躍

金斯瑞生物科技(01548)根據股份期權計劃發行123.33萬股

【金斯瑞生物科技(01548.HK)根據股份期權計劃發行123.33萬股】智通財經APP訊，金斯瑞生物科技(01548.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=13"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":2304.1912,"timestamp":1753258112924,"preClose":2226.7498,"halted":0,"volume":265978926,"delay":0,"changeRate":0.034778,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":77.441406,"latestTime":"07-23 16:00:00","open":2227.8032,"high":2393.4688,"low":2227.8032,"amount":7151248193,"amplitude":0.074398,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1753320600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753234200000,1753243200000],[1753246800000,1753257600000]],"pbRate":2.652977,"peRate":12.663954,"turnoverRate":0.02312,"increases":7,"decrements":1,"flats":0,"marketCap":521052833792,"floatMarketCap":212819887104},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2393.4688,"amplitude":0.074398,"preClose":2226.7498,"low":2227.8032,"pbRate":"2.652977","latestPrice":2304.1912,"volume":265978926,"delay":0,"open":2227.8032,"prevYearClose":1395.7731,"prevWeekClose":2262.402,"prevMonthClose":1988.255,"prevQuarterClose":1988.255,"fiveDayClose":2134.404,"twentyDayClose":1981.716,"sixtyDayClose":1649.561,"secType":"PLATE","market":"HK","turnoverRate":0.02312,"peRate":12.663954,"marketCap":521052833792,"floatMarketCap":212819887104,"timestamp":1753258112924,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":8,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:13,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550135486","title":"藥明生物(02269)出現大手買入19.95萬股，成交價$25.7，涉資512.715萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2550135486","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550135486?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 14:40","pubTimestamp":1752129600,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午02:40出现大手买入，成交量为19.95万，成交价为港币$25.7，涉资512.715万。至目前为止，股价跌0.965%，今日最高价为$26.3，而最低价为$25.6，总成交量为1.537千万股，总成交金额港币$3.972亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2507105255/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0516423174.USD","LU1242518857.USD","LU1242518931.SGD","LU0417516738.SGD","LU0181495838.USD","LU0051755006.USD","LU1794554557.SGD","LU0039217434.USD","SG9999002463.SGD","LU0326950275.SGD","LU0823426480.USD","02269","LU0456827905.SGD","LU0516423091.SGD","LU0588546209.SGD","LU0348735423.USD","LU0516422440.USD","LU0979878070.USD","LU1688375341.USD","BK1589","LU0856984785.SGD","LU0417516902.SGD","LU0140636845.USD","LU0348825331.USD","BK1521","LU0819121731.USD","LU0516422366.SGD","BK1610","LU1880383366.USD","LU0052750758.USD","LU0823426308.USD","LU0708995583.HKD","IE00B0JY6N72.USD","BK1576","LU0572944931.SGD","SG9999002562.SGD","LU0307460666.USD","LU0327786744.USD","LU0359201612.USD","LU0359202008.SGD","LU1720050803.USD","LU0456846285.SGD","LU0043850808.USD","LU0320764599.SGD","LU0516422952.EUR","BK1141","LU2039709279.SGD"],"gpt_icon":0},{"id":"2550069489","title":"聯邦制藥(03933)：UBT37034注射液獲美國FDA新藥臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069489","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550069489?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 12:31","pubTimestamp":1752121888,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药 发布公告，于2025年7月4日，公司全资附属公司联邦生物科技有限公司研发的1类创新药UBT37034注射液关于超重或肥胖适应症的新药临床试验注册申请获美国食品药品监督管理局批准，IND编号为175188。UBT37034注射液是由联邦生物科技开发的具有独立自主知识产权的1类创新药。UBT37034是一款新型多肽类受体激动剂，可通过选择性作用于神经肽Y2受体减轻体重。临床前多种动物模型研究结果显示，UBT37034与GLP-1类似物联用能够显著降低体重。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1316097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933","BK1576","BK1583","03347","BK1191","BK1141"],"gpt_icon":0},{"id":"2550919386","title":"康諾思騰自主創新研發手術機器人 於英國啓動首輪臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2550919386","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550919386?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 12:03","pubTimestamp":1752120180,"startTime":"0","endTime":"0","summary":"香港创新型手术机器人代表企业康诺思腾(Cornerstone Robotics)宣布，其于香港本地自主研发的手术机器人系统Sentire思腾腔镜手术机器人(C1000)正式于英国朴茨茅斯大学医院国民保健信托旗下亚历山德拉皇后医院启动首轮临床试验。(hc/w)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241219145546393_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241219145546393_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1452396/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","03347","BK1576","BK1141"],"gpt_icon":0},{"id":"2550912636","title":"昭衍新藥盤中異動 股價大漲5.14%報20.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550912636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550912636?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 11:58","pubTimestamp":1752119917,"startTime":"0","endTime":"0","summary":"2025年07月10日临近午盘11时58分，昭衍新药股票出现异动，股价急速拉升5.14%。截至发稿，该股报20.650港元/股，成交量486.407万股，换手率4.09%，振幅7.08%。资金方面，该股资金流入4718.61万港元，流出2873.74万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，奥星生命科技、北海康成-B、三叶草生物-B涨幅较大，振幅较大的相关个股有奥星生命科技、北海康成-B、正大企业国际，振幅分别为23.19%、21.74%、18.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710115837a441a5f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710115837a441a5f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2550695222","title":"泰格醫藥(03347)股價上升5.038%，現價港幣$49.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2550695222","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550695222?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 10:34","pubTimestamp":1752114840,"startTime":"0","endTime":"0","summary":"[上升股]泰格医药(03347) 股价在上午10:34比前收市价上升5.038%，现股价为港币$49.0。至目前为止，今日最高价为$49.0，而最低价为$45.7。总成交量为289.579万股，总成交金额为港币$1.368亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2507101003/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0077","300347","BK0174","LU1146622755.USD","BK0028","BK1583","LU1820825898.SGD","03347","BK0216","BK1576","BK1141"],"gpt_icon":0},{"id":"2550664150","title":"無錫藥明康德實施2025年首次A股回購計劃 累計回購近300萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2550664150","media":"中访网数据","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550664150?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 08:04","pubTimestamp":1752105862,"startTime":"0","endTime":"0","summary":"中访网数据  无锡药明康德新药开发股份有限公司近日披露了2025年首次A股回购计划的实施进展。根据公告，公司自2025年6月26日至7月9日期间，通过集中竞价交易方式累计回购A股股份2,891,781股，占公司总股本的约0.12%，回购价格区间为每股65.96元至70.90元，总支付金额约2亿元人民币。此次回购是依据公司2025年3月17日公告的股份回购方案执行，该方案已通过3月26日通函及4月29日股东大会决议批准。公司总股本目前为24.85亿股，回购后库存股份为零。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710081415953cbbb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710081415953cbbb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU2045819591.USD","BK1141","02359","LU0320764599.SGD","LU0708995583.HKD","LU1046422090.SGD","LU0052750758.USD","LU2125910500.SGD","LU2242644610.SGD","BK1583"],"gpt_icon":0},{"id":"2550599496","title":"上證180醫藥衞生指數上漲2.21%，前十大權重包含藥明康德等","url":"https://stock-news.laohu8.com/highlight/detail?id=2550599496","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550599496?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 23:05","pubTimestamp":1752073525,"startTime":"0","endTime":"0","summary":"数据统计显示，上证180医药卫生指数近一个月上涨0.34%，近三个月上涨11.18%，年至今上涨10.44%。据了解，上证180行业指数系列从上证180指数样本中，按中证行业分类标准进行分类，再以各自行业全部证券作为相应行业指数的指数样本，形成上证180行业指数系列，以反映上证180指数样本中不同行业证券的整体表现。从上证180医药卫生指数持仓样本的行业来看，医药卫生占比100.00%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09230551595251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1969619763.USD","LU2242644610.SGD","BK1576","BK1141","LU2045819591.USD","LU1997245094.SGD","LU0320764599.SGD","LU1997245177.USD","LU2495084118.USD","02359","LU0456842615.SGD","BK1583","LU2328871848.SGD","LU0052750758.USD","BK0216","LU1997244956.HKD","LU1046422090.SGD","LU2488822045.USD","LU2125910500.SGD","000010.SH","603259","LU0708995583.HKD"],"gpt_icon":0},{"id":"2550593346","title":"【和鉑醫藥-B(02142.HK)：恩凱賽藥已完成A+++輪融資 融資近1億元】智通財經APP訊，和鉑醫藥-B(0214","url":"https://stock-news.laohu8.com/highlight/detail?id=2550593346","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550593346?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 23:00","pubTimestamp":1752073251,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MCNHmain","BK1574","02142","MUCmain","CNHmain","BK1141","BK1161","CYB","UCmain","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2550092632","title":"【藥明生物(02269.HK)7月9日耗資約2.98億港元回購1150萬股】智通財經APP訊，藥明生物(02269.HK","url":"https://stock-news.laohu8.com/highlight/detail?id=2550092632","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550092632?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 20:16","pubTimestamp":1752063399,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0516422952.EUR","LU0181495838.USD","BK1610","LU0327786744.USD","LU0140636845.USD","LU0359202008.SGD","LU1720050803.USD","IE00B0JY6N72.USD","LU0051755006.USD","BK1576","LU1242518931.SGD","LU0320764599.SGD","LU0052750758.USD","LU0039217434.USD","LU0359201612.USD","LU0348825331.USD","LU0307460666.USD","LU1688375341.USD","02269","LU1794554557.SGD","LU2039709279.SGD","BK1521","LU0588546209.SGD","LU0856984785.SGD","BK1589","LU0417516902.SGD","LU0516422366.SGD","LU0417516738.SGD","LU0326950275.SGD","BK1141","LU0823426308.USD","LU0043850808.USD","LU0456846285.SGD","LU0572944931.SGD","SG9999002463.SGD","LU0516423091.SGD","LU0823426480.USD","LU0516422440.USD","LU0708995583.HKD","LU0979878070.USD","LU0456827905.SGD","SG9999002562.SGD","LU0516423174.USD","LU1242518857.USD","LU1880383366.USD","LU0819121731.USD","LU0348735423.USD"],"gpt_icon":0},{"id":"2550639368","title":"復宏漢霖(2696.HK)HLX43獲多國批准開展NSCLC國際多中心II期臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2550639368","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550639368?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 18:39","pubTimestamp":1752057574,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TGA","LU1169590202.USD","09997","BK1100","BK1161","BK4213","BK1222","159883","BK4023","PD","BK1141","BK1574","LU1169589451.USD","BK1576","TGA.AU","BK1583","09996","03347","BK4231","BK4080","02696","ADC","BK7001","ADC.AU","BK7095"],"gpt_icon":0},{"id":"2550636084","title":"智飛生物：重組帶狀皰疹疫苗獲臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2550636084","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550636084?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 18:33","pubTimestamp":1752057227,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1576","LU1328615791.USD","BK1583","BK1141","BK0188","159646","LU1064130708.USD","BK0239","LU1064131003.USD","03347","LU2148510915.USD","BK0077","LU2580892789.USD","LU2580892862.HKD","BK0046","300122","BK0196"],"gpt_icon":0},{"id":"2550885633","title":"【復星醫藥(02196.HK)：復邁寧®用於治療兒童低級別腦膠質瘤於中國境內啓動Ⅲ期臨牀試驗】智通財經APP訊，復星醫藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2550885633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550885633?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 17:44","pubTimestamp":1752054289,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["600196","BK1515","BK0012","BK0239","BK1141","BK1576","BK0188","BK0096","BK0060","BK0175","BK0187","BK0028","BK1593","02196","BK1583","BK0196","03347","BK0183","BK1191"],"gpt_icon":0},{"id":"2550333416","title":"【熱門行業】創新藥板塊逆勢上漲 政策+出海雙輪驅動價值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2550333416","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550333416?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 17:44","pubTimestamp":1752054261,"startTime":"0","endTime":"0","summary":"中国创新药开始具备国际化竞争力国泰海通证券指出，特朗普上台后对美国药价及医药产业多次发出威胁，要求实施最惠国价格、以医药关税等政策。中金指出，短期ASCO众多临床数据披露，以及三生为代表的大额BD落地，进一步证实中国创新药开始具备国际化竞争力。下半年ESMO会议的召开，以及围绕会议前后的数据披露与BD将对创新药有较为积极催化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MTA4MTkwNzU5Nzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MTA4MTkwNzU5Nzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1961949","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01276","BK1593","BK1574","IE00BZ08YR35.GBP","BK1576","BK1583","BK1161","BK1606","01530","BK1191","BK1589","02186","01177","BK1521","02616","IE00BZ08YT58.USD","06955","BK1141","159992","03347","IE00BZ08YS42.EUR","06978"],"gpt_icon":1},{"id":"2550638294","title":"尾盤A股突變！銀行板塊再度走強 創新藥概念盤中走勢活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638294","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550638294?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 17:41","pubTimestamp":1752054093,"startTime":"0","endTime":"0","summary":"银行板块强势银行板块今日再度走强，截至收盘，厦门银行涨逾4%，渝农商行、张家港行涨约3%。值得注意的是，工商银行、农业银行等盘中均创出新高。创新药概念活跃创新药概念盘中走势活跃，截至收盘，普蕊斯涨超17%，盘中一度20%涨停；美迪西涨超13%，九芝堂涨停，昭衍新药、恒瑞医药涨超7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709174156953bfc55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709174156953bfc55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06978","601398","BK1141","600276","601288","06127","688202","BK1574","BK1161"],"gpt_icon":0},{"id":"2550638459","title":"金斯瑞生物科技(01548)根據股份期權計劃發行123.33萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638459","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550638459?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 17:32","pubTimestamp":1752053539,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金斯瑞生物科技(01548)发布公告，于2025年7月9日，该公司根据2015年12月7日通过的上市后股份期权计划行使的股份期权而发行123.33万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1315760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","BK1141","HK0000320223.HKD","HK0000306701.USD","01548","BK1576","HK0000306685.HKD","BK1583"],"gpt_icon":0},{"id":"2550453638","title":"【金斯瑞生物科技(01548.HK)根據股份期權計劃發行123.33萬股】智通財經APP訊，金斯瑞生物科技(01548.","url":"https://stock-news.laohu8.com/highlight/detail?id=2550453638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550453638?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 17:32","pubTimestamp":1752053539,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","HK0000306701.USD","01548","HK0000320223.HKD","HK0000320264.USD","BK1583","HK0000306685.HKD","BK1576"],"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":13,"totalSize":256,"code":"91000000","status":"200"}]}}